Mersana Therapeutics Inc (MRSN)
2.625
-0.08
(-3.14%)
USD |
NASDAQ |
May 13, 16:00
2.625
0.00 (0.00%)
After-Hours: 16:44
Mersana Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Amicus Therapeutics Inc | 87.71% |
Geron Corp | -- |
Insmed Inc | 76.88% |
Altimmune Inc | -- |
InfuSystems Holdings Inc | 46.84% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -256.0% |
Return on Assets | -60.00% |
Return on Invested Capital | -186.3% |
Profit Margin (Quarterly) | -182.6% |
Operating Margin (Quarterly) | -195.6% |
Return on Net Operating Assets | -895.3% |